行业盛典 再启新程|第七届中国医药创新与投资大会初版日程发布

WANG Qinghua

State Specially Recruited Experts, CEO & General Manager of Innogen Pharmaceutical Technology Co., Ltd.

Doctoral advisor, Distinguished Professor of Fudan University, Professor of Endocrinology Department of Huashan Hospital, Deputy head of Fudan University Institute for endocrine and diabetes. Project leader of National Major Scientific and Technological Special Project for “Significant New Drugs Development” during the Twelfth Five-year Plan Period and the Thirteenth Five-year Plan Period. Professor Wang also served as an evaluation expert in CDE drug review, national major special projects, NSFC Key Fund, National Innovation Talent and Talent Fund, including Cheung Kong Scholars Programme, The National Science Fund for Distinguished Young Scholars. His team focuses on islet physiological function, β cell regeneration mechanisms, and is dedicated to diabetes translational medicine. Professor Wang is currently the Director of islet Physiology Laboratory at St. Michael's Hospital in Canada, a judge of a variety of international research and awards funds (including NIH, JDRF, MRC, CIHR) and member of editorial board of several international scientific journals, as well as a scientific medical consultant at Diamyd Medical.